AbbView has announced it has bought the rights for development and commercialisation of RGX-314. This gene therapy product has been...

At a recent meeting, the FDA advised a cautious approach for gene therapy trials. The two day CTGTAC meeting discussed the toxicity...

The FDA has halted testing of BioMarin's AAV based gene therapy drug after liver cancer developed in treated mice. BioMarin's BMN_307...

The Cellular, Tissue and Gene Therapies Advisory Committee held a virtual public meeting meeting on 2-3rd September on the toxicity risks...

The ASGCT sponsored a roundtable event of talks by industry experts on AAV integration. These discussions were extremely interesting and...